● banking

AI Based Solution Instant Loans

Dhaka Bank has signed an agreement with CASHe Alliance Ltd in order to manage technological support to roll out the new product. The lender would start disbursing loans in this manner from next month on a pilot basis. Dhaka Bank will scrutinise the credit status of loan seekers by verifying their credit information bureau report of the central bank. The lender will disburse the loan by using AI technology, which will verify the clients' behaviour through their accounts on social media. This will help the lender know the attitude and aptitude of its clients. Read More

● Healthcare

AI Driven Pipeline of Precision-Engineered Medicines

Sanofi and Exscientia has announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples. Exscientia and Sanofi will collaborate to identify and select target projects, leveraging Exscientia’s personalised medicine platform. The platform enables a “patient-first” approach through integrating primary human tissue samples into early target and drug discovery research. By doing so, Exscientia scientists can integrate patient, disease, and clinically relevant data into decisions on potential new medicine candidates earlier in the drug creation process. Read More

● Healthcare

AI Based Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds

Mydecine Innovations Group, a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has announced that they have completed a target-based model of the classic psychedelic serotonin receptor 5-HT2A for use in their AI-driven drug discovery program. The new model will allow them to expeditiously screen billions of structures to determine which novel compounds are most likely to increase binding affinity, enabling them to continue creating improved second and third generation psychedelic molecules for medical use. Read More

● Technology

AI Enabled Domain Controller SoC Family for Single-Chip Multi-Sensor Perception, Fusion and Path Planning in ADAS to L4 Autonomous Vehicles

Ambarella, Inc., an AI vision silicon company, has announced during CES the CV3 AI domain controller family. This fully scalable, power-efficient CVflow family of SoCs provides the automotive industry’s highest AI processing performance, at up to 500 eTOPS, representing a 42x increase over Ambarella’s prior automotive family. This family enables centralized, single-chip processing for multi-sensor perception including high-resolution vision, radar, ultrasonic and lidar as well as deep fusion for multiple sensor modalities and AV path planning. Read More

● Automobile

AI Based Platform that brings pioneering ADAS perception to Nextbase iQ dashcams to advance road safetyF

Humanising Autonomy has partnered with Nextbase, the world's leading dashcam manufacturer, to provide state-of-the-art ADAS perception to the Nextbase iQ product line. Running on Ambarella silicon and powered by Humanising Autonomy's Behaviour AI Platform, its analysis and prediction of human behaviours generates driver alerts much earlier and with a higher degree of accuracy than other ADAS systems available on the market. This new generation of dashcams will empower drivers with real-time collision warnings, accurate blind spot detection for rear- or side-facing cameras and will enable up to a 10x reduction in false positives. Read More